Follistatin-Like 1 Regulates Hypertrophy in Heart Failure With Preserved Ejection Fraction

Heart failure with preserved ejection fraction (HFpEF) accounts for ∼50% of all clinical presentations of heart failure, (HF) and its prevalence is expected to increase. However, there are no evidence-based therapies for HFpEF; thus, HFpEF represents a major unmet need. Although hypertension is the...

Full description

Bibliographic Details
Published in:JACC: Basic to Translational Science
Main Authors: Komei Tanaka, MD, PhD, María Valero-Muñoz, PhD, Richard M. Wilson, BS, Eric E. Essick, PhD, Conor T. Fowler, BS, Kazuto Nakamura, MD, PhD, Maurice van den Hoff, PhD, Noriyuki Ouchi, MD, PhD, Flora Sam, MD
Format: Article
Language:English
Published: Elsevier 2016-06-01
Subjects:
cardiac hypertrophy
follistatin-like 1
heart failure with preserved ejection fraction
Online Access:http://www.sciencedirect.com/science/article/pii/S2452302X16300225

Internet

http://www.sciencedirect.com/science/article/pii/S2452302X16300225

Similar Items